IPOGrid
0001835615
IPO filing research
Meihua International Medical Technologies Co., Ltd.
Surgical & Medical Instruments & Apparatus · MHUAF
follow-on
effective
OTC
EFFECT
Meihua International Medical Technologies Co., Ltd. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: EFFECT on 2026-02-26. Current deal snapshot: exchange OTC.
Filing Timeline
SEC EDGAR
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows DRS and marks the registration effective.
2026-02-26 · 9999999995-26-000681
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2026-02-13 · 0001213900-26-016606
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows F-1/A and confirms the priced prospectus.
2025-07-24 · 0001213900-25-067184
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows F-1/A in the pre-IPO sequence.
2025-04-25 · 0001213900-25-035216
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows F-1/A and confirms the priced prospectus.
2024-04-30 · 0001213900-24-037837
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows F-1/A in the pre-IPO sequence.
2024-04-24 · 0001213900-24-035784
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows F-1/A and marks the registration effective.
2024-02-27 · 9999999995-24-000565
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows F-1 and confirms the priced prospectus.
2024-02-27 · 0001213900-24-017525
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
1,205,255 shares
Warrants to Purchase 1,205,255 Ordinary Shares · Exchange Nasdaq Capital Market · Ticker MHUA · Warrants exercisable at $2.9869 per share for 1,205,255 ordinary shares · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds · Flags cayman_holding_company, foreign_private_issuer · Underwriters Selling Shareholders
2024-02-23 · 0001213900-24-016302
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
2024-02-21 · 0001213900-24-015822
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
1,205,255 shares
Warrants to Purchase 1,205,255 Ordinary Shares · Exchange Nasdaq Capital Market · Ticker MHUA · Warrants to purchase 1,205,255 ordinary shares exercisable at $2.9869 per share · Selling stockholders only · Use of proceeds No proceeds to the company; selling shareholders bear costs · Flags foreign_private_issuer, cayman_holding_company · Underwriters Selling Shareholders
2024-02-06 · 0001213900-24-010298
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows DRS/A and confirms the priced prospectus.
2024-01-02 · 0001213900-24-000216
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2023-09-29 · 9999999995-23-002881
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS/A in the pre-IPO sequence.
2023-04-14 · 0001213900-23-029709
20-F
supplemental
20-F
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS in the pre-IPO sequence.
2022-07-29 · 0001213900-22-042817
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $10.00 · Range $10.00 to $10.00 · 3,600,000 shares · Gross proceeds $36,000,000
Ordinary Shares · Exchange Nasdaq Global Market · Ticker MHUA · Over-allotment 540,000 · Flags cayman_holding_company
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of 3,600,000 ordinary shares at $10.00 per share, listed on Nasdaq under the symbol MHUA. The company, structured as a Cayman Islands exempted company, operates through wholly-owned subsidiaries in China. Upon completion, the founder, Yongjun Liu, and his wife, Yin Liu, will beneficially own 67.52% (or 66.01% with full over-allotment) of the voting power. The offering includes underwriting discounts and proceeds allocated to the company after expenses.
2022-02-17 · 0001213900-22-008227
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
Meihua International Medical Technologies Co., Ltd. filed a Form F-1 registration statement with the SEC, becoming effective on February 15, 2022. The filing registers ordinary shares for trading on Nasdaq, incorporating by reference the initial registration statement dated August 10, 2021. The company is organized under Cayman Islands law and is headquartered in China.
2022-02-15 · 9999999995-22-000465
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
The current filing for Meihua International Medical Technologies Co., Ltd. appears to be a corrupted or incomplete PDF document, as the text content is non-readable and contains binary data. The previous filing (EFFECT) was a standard SEC Notice of Effectiveness for Form F-1, indicating the company's registration statement became effective. No substantive details about the company's operations, financials, or IPO terms are visible in the current filing text.
2022-02-15 · 0001354457-22-000138
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows F-1/A and registers the class of securities for exchange listing.
Meihua International Medical Technologies Co., Ltd. filed Form 8-A12B to register ordinary shares for listing on Nasdaq, incorporating by reference the securities description from its prior F-1/A registration statement. The filing focuses on the registration of shares under Section 12(b) of the Exchange Act, with no new offering details provided beyond the initial registration.
2022-02-15 · 0001213900-22-007800
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Range $9.00 to $11.00 · 5,000,000 shares
Ordinary Shares, par value US$0.0005 per share · Exchange Nasdaq Global Market · Ticker MHUA · Use of proceeds Research and development, product development, and production expansion · Flags cayman_holding_company
Meihua International Medical Technologies Co., Ltd. is conducting an IPO of 5 million ordinary shares at an estimated price of $10.00 per share, with proceeds expected to be $46.25 million. The company, a Cayman Islands exempted company, operates through wholly-owned subsidiaries in China, focusing on disposable medical devices. The offering is structured under a direct holding model, with potential risks related to Chinese regulatory scrutiny, the HFCAA, and dividend distribution constraints. The company is an emerging growth company eligible for reduced reporting requirements.
2022-02-08 · 0001213900-22-005873
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
Price $10.00 · Range $9.00 to $11.00 · 5,000,000 shares · Gross proceeds $50,000,000
Ordinary Shares · Exchange Nasdaq Global Market · Ticker MHUA · Over-allotment 750,000 · Use of proceeds Acquisition of a local disposable medical device manufacturer, expansion of production lines, research and development, and working capital · Flags foreign_private_issuer
Meihua International Medical Technologies Co., Ltd. is offering 5,000,000 ordinary shares at an estimated price of $10.00 per share, with proceeds allocated to factory construction, production line acquisitions, R&D, and other operational improvements. The company operates through three wholly-owned subsidiaries in China, distributing Class I, II, and III disposable medical devices. Its revenue model combines in-house manufacturing and third-party resales, with a focus on domestic and international markets. The offering is subject to risks related to China's regulatory environment and compliance with U.S. securities laws.
2022-02-03 · 0001213900-22-005104
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
Range $9.00 to $11.00 · 5,000,000 shares
Ordinary Shares, par value US$0.0005 per share · Exchange Nasdaq Global Market · Ticker MHUA · Use of proceeds Research and development, product development, and expansion of production capacity · Flags cayman_holding_company, foreign_private_issuer
Meihua International Medical Technologies Co., Ltd. is conducting an IPO of 5,000,000 ordinary shares at an estimated price range of $9.00 to $11.00 per share, aiming to list on Nasdaq under the ticker MHUA. The offering is on a firm commitment basis, with proceeds intended for research and development, production expansion, and other corporate purposes. The company, structured through Cayman Islands and Chinese subsidiaries, faces regulatory and geopolitical risks tied to its China operations.
2022-02-03 · 0001213900-22-005093
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
Meihua International Medical Technologies Co., Ltd. is a provider of Class I, II, and III disposable medical devices in China, operating through three wholly-owned subsidiaries. The company's business model includes manufacturing and distributing medical devices under its own brands and reselling products from other manufacturers. The current filing relates to an initial public offering (IPO) of ordinary shares, with proceeds allocated to factory construction, production line acquisitions, R&D, and other operational improvements. The offering is underwritten by Prime Number Capital LLC, with a 365-day lock-up period for insiders.
2022-01-25 · 0001213900-22-003554
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company, a Cayman Islands exempted company with operations in China, faces risks related to Chinese government regulation, U.S. securities laws (including the HFCAA), and dividend distribution restrictions. The IPO aims to list shares on the Nasdaq Global Market under the symbol MHUA, with proceeds intended for research and development and expansion. The filing highlights structural cash flow mechanisms and regulatory challenges in China.
2021-12-29 · 0001213900-21-067820
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Ordinary Shares · Exchange Nasdaq Global Market · Ticker MHUA · Use of proceeds To fund research and development, product development, and production capacity expansion · Flags cayman_holding_company, foreign_private_issuer
Meihua International Medical Technologies Co., Ltd., a Cayman Islands exempted company, is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company operates in China through wholly-owned subsidiaries and faces risks related to Chinese government regulations, capital controls, and dividend restrictions. The IPO aims to list shares on the Nasdaq Global Market under the symbol MHUA, though there is no assurance of successful completion. The offering includes potential over-allotment options and underwriting discounts, with proceeds intended for research and development.
2021-12-02 · 0001213900-21-062899
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, structured through Cayman Islands and Chinese subsidiaries, operates in the medical technology sector. The offering includes underwriter warrants and potential over-allotment options, with proceeds intended for research and development. The filing highlights risks related to Chinese regulatory scrutiny, capital controls, and tax implications.
2021-11-05 · 0001213900-21-056849
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, a Cayman Islands exempted company with operations in China, has no prior public market for its shares. The offering includes underwriters' warrants and potential over-allotment options. The company is an emerging growth entity with risks tied to Chinese regulatory scrutiny, capital controls, and tax implications.
2021-10-21 · 0001213900-21-054048
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, incorporated in the Cayman Islands, operates through wholly-owned subsidiaries in China. Prior to this offering, there was no public market for its shares. The IPO price is expected to be $[__________] per share, with proceeds intended for general corporate purposes. The company is an emerging growth company eligible for reduced reporting requirements.
2021-09-24 · 0001213900-21-049664
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Gross proceeds $60,000,000
Ordinary Shares · Exchange Nasdaq Global Market · Ticker MHUA · Underwriters' warrants to purchase up to 6% of the shares at 120% of the public offering price · Use of proceeds Proceeds will be used for general corporate purposes · Flags cayman_holding_company
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market. The company, incorporated in the Cayman Islands, operates in China through wholly-owned subsidiaries. The offering includes underwriter warrants and an over-allotment option, with proceeds intended for general corporate purposes. The company is an emerging growth company under U.S. securities laws.
2021-09-13 · 0001213900-21-047519
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
Gross proceeds $50,000,000
Ordinary Shares, par value US$0.0005 per share · Exchange Nasdaq Global Market · Underwriters' warrants to purchase up to 10% of the ordinary shares at 120% of the public offering price, exercisable within 4 years · Flags cayman_holding_company
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market. The company, structured as a Cayman Islands exempted company, operates primarily in China through wholly-owned subsidiaries. The offering includes underwriter warrants and an over-allotment option. The company is an emerging growth company eligible for reduced reporting requirements, with significant risks tied to Chinese regulatory environments and government oversight.
2021-08-31 · 0001213900-21-045895
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Gross proceeds $50,000,000
Ordinary Shares · Exchange Nasdaq Global Market · Underwriter warrants to purchase up to 10% of the Ordinary Shares at 120% of the offering price · Use of proceeds General corporate purposes · Flags cayman_holding_company, warrants · Underwriters Prime Number Capital LLC
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company, a Cayman Islands exempted company, operates in the medical technology sector in China. The offering is structured to raise up to $50 million, with underwriter warrants and an over-allotment option. The company is an emerging growth company, eligible for reduced reporting requirements, and plans to list on the Nasdaq Global Market. Prior to this offering, there was no public market for its shares.
2021-08-10 · 0001213900-21-041150
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The offering involves underwriters' warrants and an over-allotment option. The company, a Cayman Islands exempted company, is an emerging growth company eligible for reduced reporting requirements. The filing includes details on the proposed offering price, underwriting discounts, and risks associated with the IPO.
2021-07-16 · 0001213900-21-037293
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Meihua International Medical Technologies Co., Ltd. filed a DRS/A amendment for its IPO, submitting a confidential draft registration statement under the Jumpstart Our Business Startups Act. The filing outlines the registration of ordinary shares and underwriter warrants, with an initial public offering price yet to be determined. The company, a Cayman Islands exempted company, plans to list on the Nasdaq Global Market. The offering is on a firm commitment basis, with underwriters selling shares and potential over-allotment options. The registration fee calculations and underwriting terms are detailed, including warrants exercisable at 120% of the offering price.
2021-06-07 · 0001213900-21-031088
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares under Form F-1, with a proposed maximum offering price of $50 million. The company, incorporated in the Cayman Islands, operates in China and focuses on medical technologies. The IPO is underwritten by The Crone Law Group P.C., with plans to list on the Nasdaq Global Market. The filing highlights the company's status as an emerging growth company and notes the risks associated with investing in its shares, including regulatory and market uncertainties.
2020-12-31 · 0001213900-20-045708
Comparable Deals
5 comparable deals
Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 5 using nearest neighbors.
Recent News
No recent news stored for this issuer.